Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 par value per share · CUSIP: 252828108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 1,000,000.00 · Class: 3.1%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 1,000,000.00 · Class: 3.1%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 1,000,000.00 · Class: 3.1%

  • VHCP Management III, LLC

    Shares: 1,000,000.00 · Class: 3.1%

  • VHCP Management EG, LLC

    Shares: 1,000,000.00 · Class: 3.1%

  • Nimish Shah

    Shares: 1,000,000.00 · Class: 3.1%

  • Bong Y. Koh

    Shares: 1,000,000.00 · Class: 3.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022007
Form type
SCHEDULE 13G/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub